KwikClick, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that KwikClick, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.29M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $157.4K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $288.2K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $606.8K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $175.6K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Apr 15, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $102.3K | Apr 15, 2022 |
| FY2021 | Dec 31, 2020 | $0 | Apr 15, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $175.6K | Apr 15, 2022 |
| FY2021 | Dec 31, 2020 | $0 | Apr 15, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.32M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.96M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($3.90M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($3.95M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($2.37M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($182.6K) | Apr 15, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.20M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.76M) | Mar 31, 2026 |
| FY2022 | Dec 31, 2022 | ($3.93M) | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | ($2.37M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($182.6K) | Apr 15, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $89.8K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $362.1K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $804.8K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.22M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $954.7K | Apr 17, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($202.1K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.23M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($2.34M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($2.58M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($1.03M) | Apr 17, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $6.7K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.7K | Apr 17, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $868.8K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.55M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.56M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.22M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.23M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $962.8K | Apr 15, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.08M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.72M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $2.83M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $795.7K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.04M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $47.9K | Apr 15, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.21M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.17M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($1.27M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $426.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | ($812.4K) | Apr 15, 2024 |
| FY2022 | Dec 31, 2020 | $914.9K | Apr 17, 2023 |
| FY2021 | Feb 19, 2020 | $0 | Apr 15, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($13.68M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($12.36M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($10.40M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($6.50M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($2.55M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($182.6K) | Apr 15, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.5K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $193.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $64.2K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $30.6K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $609.9K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $772.5K | Apr 15, 2022 |
| FY2021 | Feb 19, 2020 | $21 | Apr 15, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 15, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 15, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.89M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 3.89M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 155.65M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 149.44M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 115.91M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 109.69M | Apr 15, 2022 |